Bipolar Disorder with Cognitive Impairments Study
A 6-Week Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy of Lurasidone Adjunctive Therapy in Improving Cognitive Functioning in Euthymic Bipolar Disorder Patients (ELICE-BD)
The purpose of this study is to examine the efficacy of lurasidone for improving cognition in patients with bipolar disorder types I and II who are not experiencing any symptoms of depression or mania, but are still experiencing cognitive impairments (e.g. difficulty with concentration, problem solving, memory etc.). Participants will go through cognitive testing throughout the study to determine efficacy of the medication.
Who Can Participate
Participants between 19 and 65 years of age with bipolar disorder type I or II, and are currently stable on a mood stabilizer but still experiencing problems with cognition may be eligible for this study. Additional criteria will be assessed by a study doctor to determine your eligibility.
Learn More About This Research Study
For more information, please contact Nicole Woods, the study coordinator at 216-369-4744.